Cargando…

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

PURPOSE: Dose escalation may improve curability in intermediate-risk prostate carcinoma. A multicenter national program was developed to assess toxicity and tumor response with hypofractionated stereotactic boost after conventional radiotherapy in intermediate-risk prostate cancer. METHODS AND MATER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasquier, David, Nickers, Philippe, Peiffert, Didier, Maingon, Philippe, Pommier, Pascal, Lacornerie, Thomas, Martinage, Geoffrey, Tresch, Emmanuelle, Lartigau, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708754/ https://www.ncbi.nlm.nih.gov/pubmed/29190707 http://dx.doi.org/10.1371/journal.pone.0187794

Ejemplares similares

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
por: Pasquier, David, et al.
Publicado: (2023)

Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer
por: Pasquier, David, et al.
Publicado: (2018)

Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control
por: Meniai-Merzouki, F., et al.
Publicado: (2018)

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center
por: Leroy, Thomas, et al.
Publicado: (2017)

Feasibility Study of Pelvic Helical IMRT for Elderly Patients with Endometrial Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2014)

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results
por: Olivier, Jonathan, et al.
Publicado: (2019)

Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016)

BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol
por: Pasquier, David, et al.
Publicado: (2018)

Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series
por: Fessart, Etienne, et al.
Publicado: (2020)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
por: Martinage, Geoffrey, et al.
Publicado: (2019)

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results
por: Dewas, Sylvain, et al.
Publicado: (2011)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
por: Taillez, Alexandre, et al.
Publicado: (2021)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety
por: Roquette, Isaure, et al.
Publicado: (2022)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2015)

GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy—study protocol
por: Pasquier, David, et al.
Publicado: (2019)

CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations
por: Conti, Alfredo, et al.
Publicado: (2015)

Image-Guided Robotic Stereotactic Radiation Therapy with Fiducial-Free Tumor Tracking for Lung Cancer
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2012)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy
por: Nesseler, Jean Philippe, et al.
Publicado: (2020)

Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
por: Lee, Dong Soo, et al.
Publicado: (2012)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life
por: Pasquier, David, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2013)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
por: Fumagalli, Ingrid, et al.
Publicado: (2012)

Role of Hypofractionated Stereotactic Radiosurgery in Recurrent Pineal Parenchymal Tumors of Intermediate Differentiation: A Case Report and Review of the Literature
por: Beduk Esen, Caglayan Selenge, et al.
Publicado: (2020)

Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
por: Dewas, Sylvain, et al.
Publicado: (2012)

Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking
por: Jarraya, Hajer, et al.
Publicado: (2013)

Accelerated partial breast irradiation using robotic radiotherapy: a dosimetric comparison with tomotherapy and three-dimensional conformal radiotherapy
por: Rault, Erwann, et al.
Publicado: (2016)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Use of a Biodegradable, Contrast-Filled Rectal Spacer Balloon in Intensity-Modulated Radiotherapy for Intermediate-Risk Prostate Cancer Patients: Dosimetric Gains in the BioPro-RCMI-1505 Study
por: Latorzeff, Igor, et al.
Publicado: (2021)

Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Zaine, Hind, et al.
Publicado: (2021)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Intracranial chordoma: radiosurgery, hypofractionated stereotactic radiotherapy and treatment outcomes
por: Napieralska, Aleksandra, et al.
Publicado: (2021)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort
por: Bruand, Marie, et al.
Publicado: (2022)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oqfcai6r27nd7uls1iifj2o38c